Carregant...
Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
BACKGROUND: HER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti-HER2/neu treatment. METHODS: We systematically...
Guardat en:
| Publicat a: | Diagn Pathol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075405/ https://ncbi.nlm.nih.gov/pubmed/27770810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0553-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|